RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
CANCERS
Collezione AOU Novara

Items : 22

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study. in Cancers / Cancers (Basel). 2023 Sep 19;15(18):4623. doi: 10.3390/cancers15184623.

2023
AOU Novara
AOU Città della Salute di Torino

Foà R; Curti A; Passamonti F; Sartor C; Buzzatti E; Barozzi E; De Roberto P; Canzi M; Santoro L; Tagliaferri E; Zappasodi P; Cerrano M; Del Principe MI; Defina M; Todisco E; Gurrieri C; Dargenio M; Bonifacio M; Scappini B; Imovilli A; Lunghi M; Lazzarotto D; Forghieri F; Salutari P; Annunziata M; Giglio F; Chiaretti S; Vitale A; Papayannidis C; et alii...

Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies. in Cancers / Cancers (Basel). 2023 Sep 18;15(18):4618. doi: 10.3390/cancers15184618.

2023
AOU Novara

Patriarca A; Gaidano G; Barone-Adesi F; Pisterna A; Scotti L; Ucciero A; Pagnoni F; Lunghi M;

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study. in Cancers / Cancers (Basel). 2023 Mar 26;15(7):1980. doi: 10.3390/cancers15071980.

2023
AOU Novara

Depenni R; Marconcini R; Rossi E; Palleschi D; Morelli MF; Banzi M; Sponghini A; Consoli F; Troiani T; Rinaldi G; Minisini A; Quaglino P; Chiarion Sileni V; Del Vecchio M; Carnevale-Schianca F; Marcon I; Queirolo P;

A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group. in Cancers / Cancers (Basel). 2023 Jul 31;15(15):3902. doi: 10.3390/cancers15153902.

2023
AOU Novara

Marvaso G; Mastroleo F; Corrao G; Zaffaroni M; Vincini MG; Borghetti P; Cuccia F; Federico M; Montesi G; Pontoriero A; Franceschini D; Franzese C; Scorsetti M; Jereczek-Fossa BA;

Tolerability, Safety and Efficacy of a Specific Rehabilitation Treatment Protocol for Axillary Web Syndrome: An Observational Retrospective Study. in Cancers / Cancers (Basel). 2023 Jan 9;15(2):426. doi: 10.3390/cancers15020426.

2023
AOU Alessandria
AOU Novara

Baricich A; Invernizzi M; Battaglia M; Loro A; Lanzotti L; Borg MB; Mittino L;

Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. in Cancers / Cancers (Basel). 2023 Jan 6;15(2):381. doi: 10.3390/cancers15020381.

2023
AOU Novara

Giacomelli L; Papa S; Giordano G; Dadduzio V; Gadaleta-Caldarola G; Paolillo R; Giannini EG; Pieri G; Mega A; Granito A; Marzi L; Masi G; Cesario S; Rancatore G; Cabibbo G; Cocuzza C; Russello M; Gallo P; Silletta M; Daniele B; Federico P; Pirisi M; Burlone ME; di Costanzo GG; Tortora R; Ramai D; Sacco R; Renzulli M; Maida M; et alii...

Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy. in Cancers / Cancers (Basel). 2023 Feb 5;15(4):1015. doi: 10.3390/cancers15041015.

2023
AOU Novara

Mahmoud AM; Gaidano G; Mouhssine S;

Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study. in Cancers / Cancers (Basel). 2023 Dec 4;15(23):5702. doi: 10.3390/cancers15235702.

2023
AOU Novara

Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A;

Richter Syndrome: From Molecular Pathogenesis to Druggable Targets. in Cancers / Cancers (Basel). 2022 Sep 24;14(19):4644. doi: 10.3390/cancers14194644.

2022
AOU Novara

Mouhssine S; Gaidano G;

Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study. in Cancers / Cancers (Basel). 2022 Jan 27;14(3):654. doi: 10.3390/cancers14030654.

2022
AO Cuneo
AOU Novara

Petrini M; Stefoni V; Zinzani PL; Tisi MC; Kovalchuk S; Tani M; Pozzi S; Musuraca G; Rosignoli C; Arcari A; D'Alò F; Luzi D; Cantonetti M; Pane F; Gini G; Cuneo A; Visco C; Margiotta Casaluci G; Stefani PM; Casadei B; Patti C; Broccoli A; Argnani L;

Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study. in Cancers / Cancers (Basel). 2022 Dec 25;15(1):125. doi: 10.3390/cancers15010125.

2022
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Agudo A; Weiderpass E; Vineis P; Matullo G; Amiano P; Saieva C; Riboli E; Heath AK; Trobajo-Sanmartín C; Schulze MB; Tumino R; Huerta JM; Kaaks R; Agnoli C; Johnson T; Sacerdote C; Rodriguez-Barranco M; Smith-Byrne K; Panico S; Filiberti RA; Rena O; Mirabelli D; Dianzani I; Grosso F; Sculco M; Allione A; Russo A; Catalano C; Magnani C; et alii...

Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review. in Cancers / Cancers (Basel). 2022 Apr 9;14(8):1898. doi: 10.3390/cancers14081898.

2022
AOU Novara

Garutti M; Griguolo G; Botticelli A; Buzzatti G; De Angelis C; Gerratana L; Molinelli C; Adamo V; Bianchini G; Biganzoli L; Curigliano G; De Laurentiis M; Fabi A; Frassoldati A; Gennari A; Marchiò C; Perrone F; Viale G; Zamagni C; Zambelli A; Del Mastro L; De Placido S; Guarneri V; Marchetti P; Puglisi F;

New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment. in Cancers / Cancers (Basel). 2021 May 27;13(11):2636. doi: 10.3390/cancers13112636.

2021
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Libener R; Mirabelli D; Dianzani I; Ferrante D; Matullo G; Magnani C; Pirazzini C; La Vecchia M; Sculco M; Grosso F; Guarrera S; Casalone E; Catalano C; Russo A; Allione A; Cugliari G;

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. in Cancers / Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Trentin L; Gentile G; Girmenia C; Martelli M; Gaidano G; Foà R; Cuneo A; Tedeschi A; Molica S; Coscia M; Noto A; Guarente V; Stelitano C; Del Poeta G; Giordano A; Rigolin GM; De Paoli L; Murru R; Gentile M; Levato L; Ielo C; Laurenti L; Ciolli S; Vitale C; Frustaci AM; Chiarenza A; Sportoletti P; Reda G; Visentin A; et alii...

How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature. in Cancers / Cancers (Basel). 2021 Feb 17;13(4):836. doi: 10.3390/cancers13040836.

2021
AOU Città della Salute di Torino
AOU Novara

Mandato VD; Singh N; Wong RW; Goia M; Disanto MG; Boldorini R; Asaturova A; Carpenito L; Sanguedolce F; Veggiani C; Ragazzi M; Dalla Dea G; de Biase D; Santandrea G; Zizzo M; De Leo A; Ardighieri L; Bernardelli G; Ricci S; De Giorgi F; Bonacini M; Mastrofilippo V; Sileo FG; Aguzzoli L; D'Ippolito G; Falbo AI; Gugnoni M; Torricelli F; Manzotti G; et alii...

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.

2021
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU Alessandria
AOU Novara

Piciocchi A; Cuneo A; Foà R; Fazi P; Neri A; Guarini A; Rigolin GM; Nanni M; De Propris MS; Della Starza I; Raponi S; Del Giudice I; Murru R; Ruocco V; Ibatici A; Varettoni M; Laurenti L; Chiarenza A; Zinzani PL; Gentile M; Molinari A; Gozzetti A; Tani M; Musuraca G; Gottardi D; Re F; Orsucci L; Liberati AM; Ilariucci F; et alii...

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.

2021
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Kluin-Nelemans HC; Dreyling M; Ladetto M; Cortelazzo S; Hermine O; Latte G; Vitolo U; Guarini A; Fabbri A; Patti C; Pascarella A; Spina M; Vallisa D; Merli F; Di Renzo N; Cabras MG; Tani M; Volpetti S; Moia R; Barbero D; Del Giudice I; Genuardi E; Drandi D; Ghislieri M; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; et alii...

Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer. in Cancers / Cancers (Basel). 2021 Aug 11;13(16):4044. doi: 10.3390/cancers13164044.

2021
AOU Novara

Perhavec A; Zagar T; Pislar N; Plavc G; Ratosa I; Franco P;

Radiotherapy with Intensity-Modulated (IMRT) Techniques in the Treatment of Anal Carcinoma (RAINSTORM): A Multicenter Study on Behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology) Gastrointestinal Study Group. in Cancers / Cancers (Basel). 2021 Apr 15;13(8):1902. doi: 10.3390/cancers13081902.

2021
AOU Novara
AOU Alessandria

Porreca A; Lucido MR; El Khouzai B; Munoz F; Macchia G; Durante O; Guido A; Rosetto ME; Niespolo RM; Lupattelli M; Galardi A; Pittoni P; Ivaldi GB; Catalano G; Gonnelli A; Osti MF; Palazzari E; Krengli M; Vagge S; Gerardi MA; De Felice F; Manfrida S; Slim N; Rosa C; Gasparini L; Franco P; Valvo F; Mantello G; Caravatta L; et alii...

DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2020 Nov 21;12(11):3470. doi: 10.3390/cancers12113470.

2020
AOU Città della Salute di Torino
AOU Novara

Mirabelli D; Libener R; Pirazzini C; Sculco M; Aspesi A; Viberti C; Ferrante D; Grosso F; Russo A; Casalone E; Allione A; Guarrera S; Catalano C; Cugliari G; Magnani C; Dianzani I; Matullo G;

Precision Medicine Management of Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2020 Mar 10;12(3):642. doi: 10.3390/cancers12030642.

2020
AOU Novara

Moia R; Patriarca A; Schipani M; Ferri V; Favini C; Sagiraju S; Al Essa W; Gaidano G;

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. in Cancers / Cancers (Basel). 2020 Jul 3;12(7):1773. doi: 10.3390/cancers12071773.

2020
AOU Città della Salute di Torino
AOU Novara

Caronna R; Corsi A; Ligia S; Di Prima A; Maestrini G; Buscicchio G; Rago A; De Paoli L; Coscia M; Vitale C; Riminucci M; Nicolai E; Porrazzo M; Gaidano G; Mauro FR;